JNJ

J&J submits touted autoimmune disease drug for FDA approval
BioPharma Dive
Thu, 08/29/24 - 11:24 am
JNJ
myasthenia gravis
FDA
nipocalimab
J&J's bid to change pay model for Stelara, Xarelto slammed
Pharmaphorum
Mon, 08/26/24 - 10:16 am
JNJ
Stelara
340B
Xarelto
Targeting AZ's Tagrisso, Johnson & Johnson's Rybrevant combo wins key FDA nod in first-line lung cancer
Fierce Pharma
Tue, 08/20/24 - 11:36 am
JNJ
AstraZeneca
FDA
non-small cell lung cancer
Rybrevant
Lazcluze
Tagrisso
J&J to buy medical device maker V-Wave for up to $1.7 bln
Reuters
Tue, 08/20/24 - 11:08 am
JNJ
M&A
Medtech
V-Wav e
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
J&J and Roche are the strongest companies in the biopharma industry, says S&P Global
Fierce Pharma
Wed, 08/14/24 - 11:20 am
S&P Global
JNJ
Roche
J&J has enough support for $6.5 bln talc settlement
Yahoo/Reuters
Tue, 08/13/24 - 11:38 am
JNJ
legal
bankruptcy
On doorstep of FDA decision, Gilead pays J&J $320M to exit licensing deal for seladelpar
Fierce Biotech
Fri, 08/9/24 - 11:23 am
Gilead Sciences
seladelpar
liver disease
JNJ
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
Will Magenta Medical’s Elevate Disrupt the MCS Market?
Medical Devices and Diagnostics Industry
Thu, 08/8/24 - 10:17 pm
Medtech
Magenta Medical
MCS
Elevate
JNJ
Impella
Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half
Pharma Voice
Thu, 08/8/24 - 11:07 am
Big Pharma
JNJ
AbbVie
Pfizer
Roche
Eli Lilly
Novo Nordisk
Merck
Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations
BioSpace
Mon, 08/5/24 - 11:21 am
Ribon Therapeutics
AbbVie
JNJ
Novartis
Pfizer
PARP inhibitors
J&J's DePuy Synthes nets clearance for Velys spine surgery robot
Fierce Biotech
Fri, 08/2/24 - 11:56 am
JNJ
Medtech
FDA
robotic surgery
spine surgery
Velys Spine system
DePuy Synthes
J&J vets burst into biotech with $165M Third Arc series A
Fierce Biotech
Tue, 07/23/24 - 11:22 am
JNJ
Third Arc Bio
funding
solid tumors
autoimmune disease
J&J seeks expanded approval for antidepressant Spravato
BioPharma Dive
Mon, 07/22/24 - 06:43 pm
JNJ
depression
Spravato
J&J drops Addex-partnered epilepsy drug after reviewing failed phase 2 trial data
Fierce Biotech
Thu, 07/18/24 - 11:20 am
JNJ
Addex Therapeutics
epilepsy
ADX71149
Janssen
Medtech firms have cut more than 14,000 jobs in the past 18 months
Medtech Dive
Thu, 07/18/24 - 11:14 am
Medtech
layoffs
diagnostics
Thermo Fisher
JNJ
GeneDx
Baxter
Abbott Labs
Cardinal Health
Becton Dickinson
Intuitive Surgical
J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses
Fierce Pharma
Tue, 07/16/24 - 12:00 pm
Inflation Reduction Act
Medicare
drug pricing
JNJ
Bristol Myers Squibb
AstraZeneca
Johnson & Johnson proposes $505M settlement with bankrupt talc miners
Fierce Pharma
Tue, 07/16/24 - 11:59 am
JNJ
legal
J&J agrees to slash Sirturo price in South Africa, prompting authorities to end antitrust probe
Fierce Pharma
Tue, 07/9/24 - 09:17 pm
JNJ
legal
Sirturo
South Africa
tuberculosis
antitrust

Pages